Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

There is no cure for atopic dermatitis (eczema), but there are treatments that can help manage this common inflammatory skin condition. Regardless of the stage of the disease, self-care is important ...

Scratching beyond the surface: Here’s all you need to know about Atopic Dermatitis as Eczema is on the rise in India. It is not just about itchy skin: Know surprising truth about Atopic ...

In addition, Thaçi added, the “safety data support the long-term use of nemolizumab for the treatment of adolescent and adult patients with moderate to severe atopic dermatitis.” The current ...

Research shows that after 60 months of treatment, 38% of patients achieved complete remission. More than one-third of patients with severe atopic dermatitis (AD), a chronic disease characterized by ...